Risk of Zika microcephaly correlates with features of maternal antibodies.


Journal

The Journal of experimental medicine
ISSN: 1540-9538
Titre abrégé: J Exp Med
Pays: United States
ID NLM: 2985109R

Informations de publication

Date de publication:
07 10 2019
Historique:
received: 12 06 2019
revised: 15 07 2019
accepted: 16 07 2019
pubmed: 16 8 2019
medline: 11 6 2020
entrez: 16 8 2019
Statut: ppublish

Résumé

Zika virus (ZIKV) infection during pregnancy causes congenital abnormalities, including microcephaly. However, rates vary widely, and the contributing risk factors remain unclear. We examined the serum antibody response to ZIKV and other flaviviruses in Brazilian women giving birth during the 2015-2016 outbreak. Infected pregnancies with intermediate or higher ZIKV antibody enhancement titers were at increased risk to give birth to microcephalic infants compared with those with lower titers (P < 0.0001). Similarly, analysis of ZIKV-infected pregnant macaques revealed that fetal brain damage was more frequent in mothers with higher enhancement titers. Thus, features of the maternal antibodies are associated with and may contribute to the genesis of ZIKV-associated microcephaly.

Identifiants

pubmed: 31413072
pii: jem.20191061
doi: 10.1084/jem.20191061
pmc: PMC6781003
doi:

Substances chimiques

Antibodies, Viral 0

Banques de données

GENBANK
['KU501215', 'KU321639.1', 'KU955593', 'KX811222', 'KJ776791']

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2302-2315

Subventions

Organisme : NIH HHS
ID : P51 OD011092
Pays : United States
Organisme : FIC NIH HHS
ID : D43 TW010540
Pays : United States
Organisme : NIH HHS
ID : P51 OD010425
Pays : United States
Organisme : NIH HHS
ID : P51 OD011107
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI138938
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI133976
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI100989
Pays : United States
Organisme : FIC NIH HHS
ID : R01 TW009504
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI104002
Pays : United States
Organisme : NIH HHS
ID : P51 OD011106
Pays : United States
Organisme : NICHD NIH HHS
ID : U54 HD083091
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI083019
Pays : United States
Organisme : FIC NIH HHS
ID : R25 TW009338
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI129479
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI145296
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI121207
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI111825
Pays : United States

Informations de copyright

© 2019 Robbiani et al.

Références

Bull World Health Organ. 2016 Nov 1;94(11):835-840
pubmed: 27821886
Nat Commun. 2018 Jan 17;9(1):263
pubmed: 29343712
Emerg Infect Dis. 2019 Aug;25(8):1485-1493
pubmed: 31075077
Nat Med. 2018 Aug;24(8):1104-1107
pubmed: 29967348
Nature. 2016 Aug 4;536(7614):48-53
pubmed: 27338953
Nat Commun. 2018 Apr 11;9(1):1391
pubmed: 29643334
Sci Adv. 2019 Feb 27;5(2):eaav3208
pubmed: 30820456
Int J Mol Sci. 2017 Aug 05;18(8):null
pubmed: 28783051
J Infect Dis. 2017 Dec 19;216(12):1501-1504
pubmed: 29272526
Cell Rep. 2018 Nov 6;25(6):1385-1394.e7
pubmed: 30403995
Emerg Infect Dis. 2017 Apr;23(4):569-573
pubmed: 28322690
PLoS Pathog. 2017 Mar 9;13(3):e1006219
pubmed: 28278237
J Immunol. 1990 Apr 15;144(8):3183-6
pubmed: 2139079
Mem Inst Oswaldo Cruz. 2015 Jun;110(4):569-72
pubmed: 26061233
Obstet Gynecol. 2016 Oct;128(4):724-30
pubmed: 27479770
Cell Host Microbe. 2018 Nov 14;24(5):731-742.e6
pubmed: 30439342
Emerg Infect Dis. 2016 May;22(5):933-5
pubmed: 27088323
Cell Host Microbe. 2016 Jul 13;20(1):83-90
pubmed: 27247001
Cell. 2017 May 04;169(4):597-609.e11
pubmed: 28475892
N Engl J Med. 2018 Mar 15;378(11):985-994
pubmed: 29539287
Arq Neuropsiquiatr. 2017 Jun;75(6):381-386
pubmed: 28658408
Science. 2019 Feb 8;363(6427):607-610
pubmed: 30733412
JAMA Ophthalmol. 2016 May 1;134(5):529-535
pubmed: 26865554
Nat Immunol. 2016 Sep;17(9):1102-8
pubmed: 27339099
MMWR Morb Mortal Wkly Rep. 2017 Jun 16;66(23):615-621
pubmed: 28617773
Nat Med. 2016 Nov;22(11):1256-1259
pubmed: 27618651
Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):7852-7
pubmed: 27354515
J Virol. 2002 Dec;76(24):13001-14
pubmed: 12438626
Nature. 2016 Dec 15;540(7633):443-447
pubmed: 27819683
Nat Commun. 2018 Jun 20;9(1):2414
pubmed: 29925843
Cell. 2018 May 17;173(5):1111-1122.e10
pubmed: 29606355
N Engl J Med. 2016 Dec 15;375(24):2321-2334
pubmed: 26943629
N Engl J Med. 2016 Jun 2;374(22):2142-51
pubmed: 27028667
Science. 2017 Nov 17;358(6365):933-936
pubmed: 28971967
Am J Trop Med Hyg. 2018 Jun;98(6):1860-1862
pubmed: 29692307
MBio. 2017 Nov 14;8(6):
pubmed: 29138300
BMJ. 2016 Apr 13;353:i1901
pubmed: 27075009
Nat Commun. 2018 Feb 2;9(1):475
pubmed: 29396410
Nature. 2018 May;557(7707):719-723
pubmed: 29795354
Adv Virus Res. 2003;60:421-67
pubmed: 14689700
BJOG. 2013 Sep;120 Suppl 2:9-26, v
pubmed: 23678873
Science. 2017 Nov 17;358(6365):929-932
pubmed: 29097492
Sci Transl Med. 2017 Oct 4;9(410):null
pubmed: 28978754
Virus Res. 2018 Aug 2;254:27-33
pubmed: 28655548
Nat Med. 2018 Mar;24(3):368-374
pubmed: 29400709
N Engl J Med. 2016 May 19;374(20):1981-7
pubmed: 27074377
Immunity. 2017 May 16;46(5):771-773
pubmed: 28514683
Clin Infect Dis. 2017 Sep 15;65(6):877-883
pubmed: 28535184
J Clin Microbiol. 2000 May;38(5):1823-6
pubmed: 10790107
Nat Immunol. 2016 Aug 19;17(9):1010-2
pubmed: 27540984
Science. 2016 Aug 19;353(6301):823-6
pubmed: 27417494
Microbiol Mol Biol Rev. 2017 Feb 8;81(1):
pubmed: 28179396
Science. 2017 Apr 14;356(6334):175-180
pubmed: 28360135
Curr Opin Virol. 2017 Feb;22:30-35
pubmed: 27936448
MMWR Morb Mortal Wkly Rep. 2016 Mar 11;65(9):242-7
pubmed: 26963593
N Engl J Med. 2016 Sep 8;375(10):1002-4
pubmed: 27463941
MBio. 2016 Jul 19;7(4):
pubmed: 27435464
Immunity. 2019 Mar 19;50(3):751-762.e5
pubmed: 30737148
Am J Reprod Immunol. 2016 Nov;76(5):348-357
pubmed: 27613665

Auteurs

Davide F Robbiani (DF)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY drobbiani@rockefeller.edu.

Priscilla C Olsen (PC)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.
Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Federico Costa (F)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT.
Faculdade de Medicina and Instituto da Saúde Coletiva, Universidade Federal da Bahia, Salvador, Bahia, Brazil.

Qiao Wang (Q)

Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.

Thiago Y Oliveira (TY)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Nivison Nery (N)

Instituto Gonçalo Moniz, Fundação Oswaldo Cruz/MS, Salvador, Bahia, Brazil.

Adeolu Aromolaran (A)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT.

Mateus S do Rosário (MS)

Hospital Geral Roberto Santos, Secretária da Saúde do Estado da Bahia, Salvador, Brazil.

Gielson A Sacramento (GA)

Instituto Gonçalo Moniz, Fundação Oswaldo Cruz/MS, Salvador, Bahia, Brazil.

Jaqueline S Cruz (JS)

Instituto Gonçalo Moniz, Fundação Oswaldo Cruz/MS, Salvador, Bahia, Brazil.

Ricardo Khouri (R)

Instituto Gonçalo Moniz, Fundação Oswaldo Cruz/MS, Salvador, Bahia, Brazil.

Elsio A Wunder (EA)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT.

Adriana Mattos (A)

Hospital Geral Roberto Santos, Secretária da Saúde do Estado da Bahia, Salvador, Brazil.

Bruno de Paula Freitas (B)

Hospital Geral Roberto Santos, Secretária da Saúde do Estado da Bahia, Salvador, Brazil.
Universidade Federal de São Paulo, São Paulo, Brazil.

Manoel Sarno (M)

Faculdade de Medicina and Instituto da Saúde Coletiva, Universidade Federal da Bahia, Salvador, Bahia, Brazil.

Gracinda Archanjo (G)

Hospital Geral Roberto Santos, Secretária da Saúde do Estado da Bahia, Salvador, Brazil.

Dina Daltro (D)

Hospital Geral Roberto Santos, Secretária da Saúde do Estado da Bahia, Salvador, Brazil.

Gustavo B S Carvalho (GBS)

Hospital Geral Roberto Santos, Secretária da Saúde do Estado da Bahia, Salvador, Brazil.

Kleber Pimentel (K)

Hospital Geral Roberto Santos, Secretária da Saúde do Estado da Bahia, Salvador, Brazil.

Isadora C de Siqueira (IC)

Instituto Gonçalo Moniz, Fundação Oswaldo Cruz/MS, Salvador, Bahia, Brazil.

João R M de Almeida (JRM)

Faculdade de Medicina and Instituto da Saúde Coletiva, Universidade Federal da Bahia, Salvador, Bahia, Brazil.

Daniele F Henriques (DF)

Instituto Evandro Chagas, Ministério da Saúde Ananindeua, Pará, Brazil.

Juliana A Lima (JA)

Instituto Evandro Chagas, Ministério da Saúde Ananindeua, Pará, Brazil.

Pedro F C Vasconcelos (PFC)

Instituto Evandro Chagas, Ministério da Saúde Ananindeua, Pará, Brazil.

Dennis Schaefer-Babajew (D)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Stephanie A Azzopardi (SA)

Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY.

Leonia Bozzacco (L)

Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY.

Anna Gazumyan (A)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Rubens Belfort (R)

Universidade Federal de São Paulo, São Paulo, Brazil.

Ana P Alcântara (AP)

Hospital Santo Amaro, Salvador, Bahia, Brazil.

Gustavo Carvalho (G)

Hospital Santo Amaro, Salvador, Bahia, Brazil.

Licia Moreira (L)

Hospital Santo Amaro, Salvador, Bahia, Brazil.

Katiaci Araujo (K)

Hospital Aliança, Salvador, Bahia, Brazil.

Mitermayer G Reis (MG)

Instituto Gonçalo Moniz, Fundação Oswaldo Cruz/MS, Salvador, Bahia, Brazil.
Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT.
Faculdade de Medicina and Instituto da Saúde Coletiva, Universidade Federal da Bahia, Salvador, Bahia, Brazil.

Rebekah I Keesler (RI)

California National Primate Research Center, University of California, Davis, Davis, CA.

Lark L Coffey (LL)

Department of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University of California, Davis, Davis, CA.

Jennifer Tisoncik-Go (J)

Washington National Primate Research Center, Seattle, WA.
Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA.
Department of Immunology, University of Washington, Seattle, WA.

Michael Gale (M)

Washington National Primate Research Center, Seattle, WA.
Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA.
Department of Immunology, University of Washington, Seattle, WA.
Department of Global Health, University of Washington, Seattle, WA.

Lakshmi Rajagopal (L)

Department of Global Health, University of Washington, Seattle, WA.
Department of Pediatrics, University of Washington, Seattle, WA.
Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA.

Kristina M Adams Waldorf (KM)

Washington National Primate Research Center, Seattle, WA.
Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA.
Department of Global Health, University of Washington, Seattle, WA.
Department of Obstetrics and Gynecology, University of Washington, Seattle, WA.

Dawn M Dudley (DM)

Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI.

Heather A Simmons (HA)

Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI.

Andres Mejia (A)

Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI.

David H O'Connor (DH)

Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI.

Rosemary J Steinbach (RJ)

Division of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Beaverton, OR.

Nicole Haese (N)

Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, OR.
Vaccine and Gene Therapy Institute, Oregon Health and Science University, Portland, OR.

Jessica Smith (J)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Portland, OR.

Anne Lewis (A)

Pathology Services Unit, Division of Comparative Medicine, Oregon National Primate Research Center, Beaverton, OR.

Lois Colgin (L)

Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, OR.

Victoria Roberts (V)

Division of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Beaverton, OR.

Antonio Frias (A)

Division of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Beaverton, OR.
Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR.

Meredith Kelleher (M)

Division of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Beaverton, OR.

Alec Hirsch (A)

Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, OR.
Vaccine and Gene Therapy Institute, Oregon Health and Science University, Portland, OR.

Daniel N Streblow (DN)

Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, OR.
Vaccine and Gene Therapy Institute, Oregon Health and Science University, Portland, OR.

Charles M Rice (CM)

Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY.

Margaret R MacDonald (MR)

Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY.

Antonio R P de Almeida (ARP)

Faculdade de Medicina and Instituto da Saúde Coletiva, Universidade Federal da Bahia, Salvador, Bahia, Brazil.

Koen K A Van Rompay (KKA)

California National Primate Research Center, University of California, Davis, Davis, CA.
Department of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University of California, Davis, Davis, CA.

Albert I Ko (AI)

Instituto Gonçalo Moniz, Fundação Oswaldo Cruz/MS, Salvador, Bahia, Brazil.
Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT.

Michel C Nussenzweig (MC)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY nussen@rockefeller.edu.
Howard Hughes Medical Institute, The Rockefeller University, New York, NY.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH